Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unm
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to
| Agency | Food and Drug Administration |
|---|---|
| Status | Posted |
| Opportunity number | RFA-FD-25-017 |
| Posted date | 07/11/2025 |
| Application deadline | Feb 08, 2028 12:00:00 AM EST |
| Award ceiling | 600,000 |
| Award floor | 0 |
| Who can apply | Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationNonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)For-Profit OrganizationsSmall BusinessesFor-Profit Organizations (Other than Small Businesses)Local GovernmentsState GovernmentsCoun |
| Assistance Listing (CFDA) | 93.103 |
| Description | The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development. |
| Agency contact | Kimberly.Pendleton@fda.hhs.gov |
| Official listing | https://www.grants.gov/search-results-detail/360007 |